This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The hypothesis of this protocol is that temporal lobe epilepsy (TLE) is a network disease, involving brain regions anatomically and functionally distant from the seizure focus. The seizure focus can cause dysfunction throughout the network in the interictal state, i.e., between seizures.
The specific aims are as follows: 1) To define the extent and severity of interictal perceptual deficits in 3 sensory modalities using basic psychophysical techniques. 2) To determine the effect of stimulus temporal features, specifically duration, on observed psychophysically-determined perceptual impairments. 3) To document the effect of removing the seizure focus on perceptual abilities. Potential subjects will be prescreened for meeting the inclusion and exclusion criteria by telephone interview with research personnel. Forty patients with unilateral, medically intractable TLE and 20 neurologically normal controls will undergo a battery of neuropsychological and perceptual psychophysical tests. Control subjects will be tested once on all tasks; TLE subjects will be tested three times: 1) baseline assessment while taking their usual anti-epileptic drugs (AEDs, initial test), 2) after substantial or complete AED withdrawal during clinically indicated, inpatient video-EEG monitoring (non-AED test), and 3) 6 months after surgery or 6 months after initial testing for those patients who ultimately do not have surgery (final test). AED levels in TLE subjects will be measured during all three testing sessions, on the first day of testing. All of the psychophysical tests are painless and non-invasive. Visual tasks involve looking at stimuli on a computer screen. Auditory stimuli are presented through high-quality headphones at a comfortable volume. Tactile stimuli are applied to the subject's fingertip with low or moderate force. Primary outcome measures will include comparing performance on the various tests between the following groups: TLE subjects - initial to normal controls, 2) paired final to initial, and 3) paired non-AED to initial. Secondary outcome measures will include initial performance on psychophysical tasks with the hand or ear contra lateral to side of seizure onset compared to hand or ear ipsilateral to side of seizure onset (visual tasks will be performed binocularly).

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000096-45
Application #
7378346
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
2006-04-01
Project End
2007-03-31
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
45
Fiscal Year
2006
Total Cost
$12,159
Indirect Cost
Name
New York University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Homann, O R; Misura, K; Lamas, E et al. (2016) Whole-genome sequencing in multiplex families with psychoses reveals mutations in the SHANK2 and SMARCA1 genes segregating with illness. Mol Psychiatry 21:1690-1695
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17
Ebbert, Mark T W; Boehme, Kevin L; Wadsworth, Mark E et al. (2016) Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk. Alzheimers Dement 12:121-129
Hohman, Timothy J; Cooke-Bailey, Jessica N; Reitz, Christiane et al. (2016) Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement 12:233-43
Li, Yi; Tsui, Wai; Rusinek, Henry et al. (2015) Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease. J Nucl Med 56:270-3
Ghani, Mahdi; Reitz, Christiane; Cheng, Rong et al. (2015) Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals. JAMA Neurol 72:1313-23
Beecham, Gary W; Dickson, Dennis W; Scott, William K et al. (2015) PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease. Neurology 84:972-80

Showing the most recent 10 out of 470 publications